Our monthly brief for decision-makers

Gain insights to operate in the international cannabis market

  • Learn about the impact of the latest laws and regulations.
 
  • Get insights on the likely evolution of regulatory reforms.
 
  • Monitor the political environment and cannabis policy papers & proposals.
 
  • Keep track of advocacy initiatives and lobbying efforts.
  • Track the latest market data: sales, imports, prescriptions, patients…
 
  • Stay up to date with M&A, supply deals, licensing & market entry.
 
  • Monitor the financial performance of the top companies in the market.
 
  • Follow new product and brand launches in international markets.

  • Track progress of clinical trials, scientific studies and R&D projects.
 
  • Follow the state of the art of cannabis science and technology.
 
  • Understand new product development trends.

Historic regulatory pivots meet market caution — December 2025

Thank you for being a Cannamonitor subscriber. You have full access to this brief—over 300 December updates across 45+ markets—plus our complete searchable database of 7,000+ regulation, market and science sources: in the Insights section you'll get access as well to the M&A Tracker mentioned below.December 2025 delivered the most significant US federal cannabis policy shift in 50 years. Trump signed an executive...

Legalisation Momentum Meets Regulatory Headwinds — October 2025 Brief

Access the database with +5,000 regulation updates, market reports and science papers on the international cannabis market. October 2025 highlighted a decisive shift toward regulatory expansion across the global cannabis landscape. Import quotas rose, hospital and pharmacy access widened, and several countries advanced long-awaited legal frameworks — signalling renewed political momentum. Yet these openings coexist with lingering frictions: online delivery bans, stalled U.S....

Regulatory scrutiny fuels market instability — September 2025 Brief

September 2025 underscored the tension between rising demand and tightening compliance across global cannabis supply chains. Imports, prescriptions, and economic contributions continue to climb, yet regulatory reviews multiply — with stricter prescribing rules and compliance crackdowns reshaping access. Some countries move boldly toward reform, while others drift in regulatory grey zones — marking a sector entering a more disciplined, mature phase. Key...

Obtain Actionable Intelligence
into Global Cannabis Markets